Newsletter

Pompe Disease
With one marketed therapy, and several in pipeline, Pompe disease market is anticipated to boost in the coming decade
Pompe Disease

More Whitepapers / Newsletters

Neuroendocrine tumors Newsletter
Neuroendocrine tumors

Neuroendocrine tumors (NET) are a rare kind neoplasm that arises from cells of the endocrine (hormonal) and nervous systems...

Chronic inflammatory demyelinating polyneuropathy market Newsletter
Chronic inflammatory demyelinating polyneuropathy market

A rare neurological disorder characterized by progressive weakness and impaired sensory function in the legs and arms...

Impact of BREXIT on Pharma Space Newsletter
Impact of BREXIT on Pharma Space

BREXIT, the 'EXIT' of 'BRITAIN' from 'EUROPEAN UNION', shook the whole world when the United Kingdom voted in the favor of leaving the EU.

Ataxia Telangiectasia Newsletter
Ataxia Telangiectasia

An autosomal recessive disorder, Ataxia Telangiectasia, affects a person's nervous system, immune system, along with the other body parts...

The Ophthalmic drug delivery therapeutics for retinal disorders Whitepaper
The Ophthalmic drug delivery therapeutics for retinal disorders Whitepaper

Delivery of therapeutics to the human eye is among the most interesting endeavours a...